Genocea Biosciences, Inc. Commences Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- S&P 500, Nasdaq futures decline as US-Iran escalation rattles sentiment
- Oil gains over 2% as fresh military strikes threaten Hormuz shipments
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Apple sues OpenAI, two former employees for trade secrets theft
Genocea Biosciences (GNCA) Prices 5.45M Common Share Offering at $8.25/Share
March 12, 2015 8:58 AM EDTGenocea Biosciences (NASDAQ: GNCA) announced the pricing of its public offering of 5,454,545 shares of its common stock at a public offering price of $8.25 per share, before underwriting discounts. In addition, Genocea has granted the underwriters a 30-day option to purchase up to an... More
Genocea Biosciences (GNCA) Plans Common Stock Offering
March 11, 2015 4:22 PM EDTGenocea Biosciences (NASDAQ: GNCA) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. As part of this proposed offering, Genocea intends to grant the underwriters a 30-day option to purchase up to an additional... More
